Mycoses in Thailand: Current concerns

Japanese Journal of Medical Mycology

Volumn 46, Issue 2, 2005, Pages 81-86

  Ungpakorn, Rataporn ^a  

^a Institute of Dermatology Thailand   (Thailand)

Author keywords

Chromoblastomycosis; Mycoses; Non dermatophyte; Penicillium marneffei; Tinea capitis

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; GRISEOFULVIN; ITRACONAZOLE; TERBINAFINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLASTOMYCOSIS; DRUG EFFICACY; FONSECAEA PEDROSOI; FUNGUS CULTURE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROSPORUM CANIS; MYCOSIS; NONHUMAN; ONYCHOMYCOSIS; PENICILLIUM MARNEFFEI; PRACTICE GUIDELINE; PREVALENCE; REVIEW; THAILAND; TINEA CAPITIS;

ARTHRODERMATACEAE; CANDIDA ALBICANS; CANIS; FONSECAEA PEDROSOI; FUNGI; HUMAN IMMUNODEFICIENCY VIRUS; MICROSPORUM; MICROSPORUM CANIS; PENICILLIUM MARNEFFEI; SCYTALIDIUM; SCYTALIDIUM DIMIDIATUM; TINEA;

EID: 19944389904     PISSN: 09164804     EISSN: None     Source Type: Journal    
DOI: 10.3314/jjmm.46.81     Document Type: Review

References (27)

1. English M, Gibson: Studies in the epidemiology of tinea pedis. Br Med J 1: 1442-1446, 1959.
2. Gentles JC, Evans EGV: Foot infections in swimming baths. Br Med J 3: 260-262, 1973.
3. Barranco V: New approaches to the diagnosis and management of onychomycosis. Int J Dermatol 33: 292-299, 1994.
4. Roberts DT: Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey. Br J Dermatol 126 (Suppl. 39): 23-27, 1992.
5. Heikkila H, Stubb S: The prevalence of onychomycosis in Finland. Br J Dermatol 133: 677-703, 1995.
6. Buxton PK, Milne LJR, Prescott RJ, et al.: The prevalence of dermatophyte infection in well-controlled diabetics and the response to Trichophyton antigen. Br J Dermatol 134: 900-903, 1996.
7. Elewski B, Charif M: Prevalence of onychomycosis in patients attending a dermatology clinic in Northeastern Ohio for other conditions. Arch Dermatol 133: 1172-1173, 1997.
8. Gupta AK, Jain HC, Lynde CW, et al.: Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' office in Ontario, Canada -a multicenter survey of 2001 patients. Int J Dermatol 36: 783-787, 1997.
9. Haneke E, Roseeuw D: The scope of onychomycosis: epidemiology and clinical features. Int J Dermatol 38(Suppl. 2): 7-12, 1999.
10. Roseeuw D: Achilles foot screening project: preliminary results of patients screened by dermatologists. J Eur Acad Dermatol Venereol 12(Suppl. 1): 6-9, 1999.
11. Pierard G: Onychomycosis and other superficial fungal infections of foot in the elderly: a pan-European survey. Dermatology 202: 220-224, 2001.
12. Aly R: Ecology and epidemiology of dermatophyte infections. J Am Acad Dermatol 31: 21-25, 1994.
13. Summerbell RC: Epidemiology and ecology of onychomycosis. Dermatology 194(Suppl. 1): 32-36, 1997.
14. Elewski BE, Greer DL: Hendersonula toruloidea and Scytalidium hyalinum: review and update. Arch Dermatol 127(7): 1041-1044, 1991.
15. Rollman O, Johansson S: Hendersonula toruloidea Infection: successful response of onychomycosis to nail avulsion and topical ciclopiroxolamine. Acta Derm Venereol (Stockh) 67: 506-510, 1987.
16. Gordon PM, Stankler L: Rapid clearing of kerion ringworm with terbinafine. Br J Dermatol 129: 503-504, 1993.
17. Kullavanijaya P, Reangchainam S, Ungpakorn R: Randomised single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis. J Am Acad Dermatol 37: 272-273, 1997.
18. Baudraz-Rosselet F, Monod M, Jaccoud S, Frenk E: Efficacy of terbinafine treatment of tinea capitis in children varies according to the dermatophytes species. Br J Dermatol 135: 1011-1012, 1996.
19. Baudraz-Rosselet F, Monod M, Harms M, Arechalde A: Oral terbinafine treatment for tinea capitis. Dermatology 193: 161, 1996.
20. Dragos V, Lunder M: Lack of efficacy of 6-week treatment with oral terbinafine for tinea capitis due to Microsporum cants in children. Pediatr Dermatol 14: 46-48, 1997.
21. Gupta AK, Adam P: Terbinafine pulse therapy is effective in tinea capitis. Pediatr Dermatol 15: 56-58, 1998.
22. Gupta AK, Hofstader LR, Adam P, Summerbell RC. Tinea capitis: An overview with emphasis on management. Fed Dermatol 16: 171-189, 1999.
23. Ungpakorn R, Ayutyanont S, Reangchainam S, Supanya S: Treatment of Microsporum spp. Tinea capitis with pulsed oral terbinafine. Clin Exp Dermatol 29: 300-303, 2004.
24. Segretain G: Penicillium marneffei n. sp., agent d'une mycose du systeme reticuloendothelial. Mycopathol Mycol Appl 11: 327-353, 1959.
25. Di Salvo DA, Fickling AM, Ajello L: Infection caused by Penicilllium marneffei. Description of first natural infection in human. Am J Clin Pathol 60: 259-263, 1973.
26. Pautler KB, Padhye AA, Ajello L: Imported penicillosis marneffei in the United States: report of a second human infection. Sabouradia. J Med Vet Mycol 22: 433-438, 1984.
27. Deng ZL, Connor DH. Progressive disseminated penicillosis caused by Penicillium marneffei: report of eight cases and differentiation of the causative organism from Histoplasma capsulatum. Am J Clin Pathol 84: 323-327, 1985.